
The clarification separates independent distribution from AIFM operational duties, lowering compliance risk while compelling managers to reassess control over third‑party marketing.
The European Union’s AIFMD II revision addresses a long‑standing ambiguity around third‑party marketing. Article 20(6a) explicitly removes marketing performed by distributors regulated under MiFID II or the Insurance Distribution Directive from the delegation framework, meaning that such activities are no longer automatically classified as delegated functions of the AIFM. This change provides legal certainty for fund managers and distributors, but it also shifts the regulatory focus from the existence of a contract to the substance of the relationship.
In practice, the key test becomes whether the distributor operates on its own behalf, decides how, when, and to whom the alternative investment fund is marketed, and fulfills its own suitability or appropriateness obligations. If the AIFM dictates marketing strategy, approves materials beyond legal checks, or controls client targeting, the arrangement may still be viewed as delegation. Consequently, firms must scrutinise existing distribution agreements for clauses that embed AIFM control, as such provisions could expose them to compliance breaches under the new regime.
To align with AIFMD II, managers should conduct a substance‑based review of all distribution relationships, tightening documentation to accurately reflect the independent nature of the marketer’s role. Updating contractual language, clarifying decision‑making authority, and ensuring distributors retain discretion are practical steps. By doing so, AIFMs can preserve the benefits of third‑party distribution while mitigating regulatory risk, positioning themselves for a smoother transition as the market adapts to the clarified independence‑versus‑control paradigm.
Comments
Want to join the conversation?
Loading comments...